filmov
tv
Evolution of HER2-Targeted Therapy in Biliary Tract Cancer
Показать описание
Do you know which type of biliary tract cancer (BTC) has the highest rate of HER2 aberrations?
Medscape
Рекомендации по теме
0:28:57
Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
0:03:45
Evolving Landscape of HER2-Targeted Therapy in Breast Cancer
0:04:45
Evolving Role of HER2-Targeted Therapy in Breast Cancer
0:28:57
For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
0:24:04
Evolution of HER2-Targeted Therapy in Biliary Tract Cancer
0:02:09
The evolution of HER2 targeting in metastatic breast breast cancer
0:04:23
Evolution of Targeted Therapy in Advanced NSCLC
0:02:22
Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer
0:56:54
10/16/2015: 'Evolution of Targeted Therapies in Breast Cancer: New Opportunities for Cure'
0:01:20
Dr. Hurvitz on the Evolution of Treatment in Metastatic HER2+ Breast Cancer
0:02:50
HER2 Targeted Therapies
0:04:20
The Evolution of Treatment Approaches for ER+ MBC
0:00:47
Dr. Pusztai on Evolution of Treatment for HER2+ Breast Cancer
1:42:45
Targeted Therapy for HER2 and HER3+ Breast Cancer: Navigating the Evolving Treatment Landscape
0:05:28
HER2-Targeted Therapy in Early Breast Cancer
0:03:24
Evolving Treatment Options in ER+ Metastatic Breast Cancer
0:01:37
Dr. Hurvitz on How to Navigate HER2-Targeted Therapy in Breast Cancer
0:03:36
HER2+ Breast Cancer: Evolution of Antibody-Drug Conjugates
0:01:48
Dr. Tolaney on the Evolution of Adjuvant Treatment for HER2+ Breast Cancer
0:01:37
Evolution of gene therapy in oncology
0:07:52
Introduction and Overview of HER2-Targeted Therapies in Breast Cancer
0:06:29
Evolving Treatment Landscape of R/R HER2+ mBC
0:00:23
Next Generation HER2 Targeted Therapies: Promising Advances in Cancer Treatment
0:01:19
Targeted therapies for patients with HER2+ colorectal cancer
0:28:57
0:03:45
0:04:45
0:28:57
0:24:04
0:02:09
0:04:23
0:02:22
0:56:54
0:01:20
0:02:50
0:04:20
0:00:47
1:42:45
0:05:28
0:03:24
0:01:37
0:03:36
0:01:48
0:01:37
0:07:52
0:06:29
0:00:23
0:01:19